2m 2m 2m 2m 2m 2m 2m
Glorywin Ent Gr Br (GWIN)
OTC
$0.66+$0.15 (+28.71%)
Price as of Sep 01, 2026- N/AMarket Cap
- 254.35%1-Year Change
- BiotechnologyIndustry
Glorywin Ent Gr Br (GWIN)
$0.66+$0.15 (+28.71%)
GWIN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.66 | ||
Change | +$0.15 (+28.71%) | ||
Open | $0.66 | ||
High | $0.66 | ||
Low | $0.66 | ||
Previous Close | $0.51 | ||
Volume | 200 | ||
30-Day Average Volume | 200 | ||
1-Week Change | 28.71% | ||
1-Month Change | 28.71% | ||
1-Year Change | 254.35% | ||
3-Year Change | 876.44% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 20.9M | ||
Total Assets | $7.8M | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | $1.9M | ||
Net Income | $1.3M | ||
Free Cash Flow | $712,230.00 | ||
EBIT | $1.5M | ||
EBITDA | $1.5M | ||
Net Working Capital | $368,772.00 | ||
EPS | $0.06 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | 23 | ||
PEG | 0 | ||
Price/Free Cash Flow | 40 | ||
Price/Operating Cash Flow | 40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||